Publication:
Survival in Southern European patients waitlisted for kidney transplant after graft failure: A competing risk analysis.

dc.contributor.authorHernández, Domingo
dc.contributor.authorMuriel, Alfonso
dc.contributor.authorCastro de la Nuez, Pablo
dc.contributor.authorAlonso-Titos, Juana
dc.contributor.authorRuiz-Esteban, Pedro
dc.contributor.authorDuarte, Ana
dc.contributor.authorGonzalez-Molina, Miguel
dc.contributor.authorPalma, Eulalia
dc.contributor.authorAlonso, Manuel
dc.contributor.authorTorres, Armando
dc.date.accessioned2024-02-08T14:41:06Z
dc.date.available2024-02-08T14:41:06Z
dc.date.issued2018-03-07
dc.description.abstractWhether patients waitlisted for a second transplant after failure of a previous kidney graft have higher mortality than transplant-näive waitlisted patients is uncertain. We assessed the relationship between a failed transplant and mortality in 3851 adult KT candidates, listed between 1984-2012, using a competing risk analysis in the total population and in a propensity score-matched cohort. Mortality was also modeled by inverse probability weighting (IPTW) competing risk regression. At waitlist entry 225 (5.8%) patients had experienced transplant failure. All-cause mortality was higher in the post-graft failure group (16% vs. 11%; P = 0.033). Most deaths occurred within three years after listing. Cardiovascular disease was the leading cause of death (25.3%), followed by infections (19.3%). Multivariate competing risk regression showed that prior transplant failure was associated with a 1.5-fold increased risk of mortality (95% confidence interval [CI], 1.01-2.2). After propensity score matching (1:5), the competing risk regression model revealed a subhazard ratio (SHR) of 1.6 (95% CI, 1.01-2.5). A similar mortality risk was observed after the IPTW analysis (SHR, 1.7; 95% CI, 1.1-2.6). Previous transplant failure is associated with increased mortality among KT candidates after relisting. This information is important in daily clinical practice when assessing relisted patients for a retransplant.
dc.format.number3es_ES
dc.format.pagee0193091es_ES
dc.format.volume13es_ES
dc.identifier.doi10.1371/journal.pone.0193091
dc.identifier.e-issn1932-6203es_ES
dc.identifier.journalPloS onees_ES
dc.identifier.otherhttp://hdl.handle.net/10668/12217
dc.identifier.pubmedID29513701es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17579
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdult
dc.subject.meshCardiovascular Diseases
dc.subject.meshCause of Death
dc.subject.meshCohort Studies
dc.subject.meshEurope
dc.subject.meshGraft Survival
dc.subject.meshHumans
dc.subject.meshKidney Transplantation
dc.subject.meshPropensity Score
dc.subject.meshRegistries
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.subject.meshSurvival Analysis
dc.subject.meshSurvival Rate
dc.subject.meshTreatment Failure
dc.subject.meshWaiting Lists
dc.titleSurvival in Southern European patients waitlisted for kidney transplant after graft failure: A competing risk analysis.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files